383 related articles for article (PubMed ID: 32692778)
1. Pre-treatment drug resistance and HIV-1 genetic diversity in the rural and urban settings of Northwest-Cameroon.
Fokam J; Takou D; Teto G; Nforbih SE; Kome OP; Santoro MM; Ngoufack ES; Eyongetah M; Palmer D; Fokunang ET; Fokunang CN; Colizzi V; Perno CF; Ndjolo A
PLoS One; 2020; 15(7):e0235958. PubMed ID: 32692778
[TBL] [Abstract][Full Text] [Related]
2. Genetic diversity and antiretroviral resistance-associated mutation profile of treated and naive HIV-1 infected patients from the Northwest and Southwest regions of Cameroon.
Meriki HD; Tufon KA; Anong DN; Atanga PN; Anyangwe IA; Cho-Ngwa F; Nkuo-Akenji T
PLoS One; 2019; 14(11):e0225575. PubMed ID: 31751428
[TBL] [Abstract][Full Text] [Related]
3. Short Communication: Population-Based Surveillance of HIV-1 Drug Resistance in Cameroonian Adults Initiating Antiretroviral Therapy According to the World Health Organization Guidelines.
Fokam J; Takou D; Santoro MM; Akonie HZ; Kouanfack C; Ceccherini-Silberstein F; Colizzi V; Perno CF; Ndjolo A
AIDS Res Hum Retroviruses; 2016 Apr; 32(4):329-33. PubMed ID: 26602836
[TBL] [Abstract][Full Text] [Related]
4. Increased HIV-1 pretreatment drug resistance with consistent clade homogeneity among ART-naive HIV-1 infected individuals in Ethiopia.
Kiros M; Alemayehu DH; Geberekidan E; Mihret A; Maier M; Abegaz WE; Mulu A
Retrovirology; 2020 Sep; 17(1):33. PubMed ID: 32993693
[TBL] [Abstract][Full Text] [Related]
5. Gag P2/NC and pol genetic diversity, polymorphism, and drug resistance mutations in HIV-1 CRF02_AG- and non-CRF02_AG-infected patients in Yaoundé, Cameroon.
Teto G; Tagny CT; Mbanya D; Fonsah JY; Fokam J; Nchindap E; Kenmogne L; Njamnshi AK; Kanmogne GD
Sci Rep; 2017 Oct; 7(1):14136. PubMed ID: 29074854
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of drug resistance mutations among ART-naive and -experienced HIV-infected patients in Sierra Leone.
Yendewa GA; Sahr F; Lakoh S; Ruiz M; Patiño L; Tabernilla A; Deen GF; Sesay M; Salata RA; Poveda E
J Antimicrob Chemother; 2019 Jul; 74(7):2024-2029. PubMed ID: 30989237
[TBL] [Abstract][Full Text] [Related]
7. High level of HIV-1 drug resistance mutations in patients with unsuppressed viral loads in rural northern South Africa.
Etta EM; Mavhandu L; Manhaeve C; McGonigle K; Jackson P; Rekosh D; Hammarskjold ML; Bessong PO; Tebit DM
AIDS Res Ther; 2017 Jul; 14(1):36. PubMed ID: 28750647
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of Antiretroviral Drug Resistance Mutations Among Pretreatment and Antiretroviral Therapy-Failure HIV Patients in Uzbekistan.
Mamatkulov A; Kazakova E; Ibadullaeva N; Joldasova E; Bayjanov A; Musabaev E; Kan N; Mustafaeva D; Lebedev A; Bobkova M; Kazennova E; Zohrabyan L
AIDS Res Hum Retroviruses; 2021 Jan; 37(1):38-43. PubMed ID: 32873061
[TBL] [Abstract][Full Text] [Related]
9. Diversity of HIV-1 genotypes and high prevalence of pretreatment drug resistance in newly diagnosed HIV-infected patients in Shanghai, China.
Wang Z; Zhang M; Zhang R; Liu L; Shen Y; Wang J; Lu H
BMC Infect Dis; 2019 Apr; 19(1):313. PubMed ID: 30961560
[TBL] [Abstract][Full Text] [Related]
10. Pre-Treatment HIV Drug Resistance and Genetic Diversity in Cameroon: Implications for First-Line Regimens.
Fokam J; Chenwi CA; Tala V; Takou D; Santoro MM; Teto G; Dambaya B; Anubodem F; Semengue ENJ; Beloumou G; Djupsa S; Assomo E; Fokunang C; Alteri C; Billong S; Bouba NP; Ajeh R; Colizzi V; Mbanya D; Ceccherini-Silberstein F; Perno CF; Ndjolo A
Viruses; 2023 Jun; 15(7):. PubMed ID: 37515146
[TBL] [Abstract][Full Text] [Related]
11. Pretreatment resistance mutations and treatment outcomes in adults living with HIV-1: a cohort study in urban Malawi.
Neuhann F; de Forest A; Heger E; Nhlema A; Scheller C; Kaiser R; Steffen HM; Tweya H; Fätkenheuer G; Phiri S
AIDS Res Ther; 2020 May; 17(1):22. PubMed ID: 32434561
[TBL] [Abstract][Full Text] [Related]
12. Dynamic HIV-1 genetic recombination and genotypic drug resistance among treatment-experienced adults in northern Ghana.
Nii-Trebi NI; Brandful JAM; Ibe S; Sugiura W; Barnor JS; Bampoh PO; Yamaoka S; Matano T; Yoshimura K; Ishikawa K; Ampofo WK
J Med Microbiol; 2017 Nov; 66(11):1663-1672. PubMed ID: 29068286
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 drug resistance testing is essential for heavily-treated patients switching from first- to second-line regimens in resource-limited settings: evidence from routine clinical practice in Cameroon.
Takou D; Fokam J; Teto G; Santoro MM; Ceccherini-Silberstein F; Nanfack AJ; Sosso SM; Dambaya B; Salpini R; Billong SC; Gori C; Fokunang CN; Cappelli G; Colizzi V; Perno CF; Ndjolo A
BMC Infect Dis; 2019 Mar; 19(1):246. PubMed ID: 30871487
[TBL] [Abstract][Full Text] [Related]
14. Characterization of drug resistance mutations in naïve and ART-treated patients infected with HIV-1 in Yaounde, Cameroon.
Ceccarelli L; Salpini R; Moudourou S; Cento V; Santoro MM; Fokam J; Takou D; Nanfack A; Dori L; Torimiro J; Sarmati L; Andreoni M; Perno CF; Colizzi V; Cappelli G
J Med Virol; 2012 May; 84(5):721-7. PubMed ID: 22431019
[TBL] [Abstract][Full Text] [Related]
15. Identification of new, emerging HIV-1 unique recombinant forms and drug resistant viruses circulating in Cameroon.
Ragupathy V; Zhao J; Wood O; Tang S; Lee S; Nyambi P; Hewlett I
Virol J; 2011 Apr; 8():185. PubMed ID: 21513545
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 subtype diversity and immuno-virological outcomes among adolescents failing antiretroviral therapy in Cameroon: A cohort study.
Togna Pabo WLR; Fokam J; Njume D; Takou D; Santoro MM; Nyasa RB; Chenwi C; Mpouel ML; Beloumou G; Jagni ESN; Nka AD; Ka'e AC; Teto G; Dambaya B; Djupsa S; Gouissi Anguechia DH; Evariste M; Kamta C; Bala L; Lambo V; Halle-Ekane EG; Colizzi V; Perno CF; Ndjolo A; Ndip Ndip R
PLoS One; 2023; 18(10):e0293326. PubMed ID: 37878637
[TBL] [Abstract][Full Text] [Related]
17. Programme quality indicators of HIV drug resistance among adolescents in urban versus rural settings of the centre region of Cameroon.
Fokam J; Nangmo A; Wandum C; Takou D; Santoro MM; Nlend AN; Ateba FN; Ndombo PK; Kamgaing N; Kamta C; Essiane A; Lambo V; Fokunang C; Mbanya D; Colizzi V; Perno CF; Ndjolo A
AIDS Res Ther; 2020 May; 17(1):14. PubMed ID: 32398107
[TBL] [Abstract][Full Text] [Related]
18. Second-line antiretroviral therapy failure and characterization of HIV-1 drug resistance patterns in children in Mali.
Sylla M; Dolo O; Maiga AI; Traore FT; Coulibaly YA; Togo J; Fofana DB; Dicko-Traore F; Doumbia S; Orsega S; Diallo S; Murphy RL; Calvez V; Marcelin AG
Arch Pediatr; 2019 Jul; 26(5):254-258. PubMed ID: 31307909
[TBL] [Abstract][Full Text] [Related]
19. Archiving of mutations in HIV-1 cellular reservoirs among vertically infected adolescents is contingent with clinical stages and plasma viral load: Evidence from the EDCTP-READY study.
Fokam J; Mpouel Bala ML; Santoro MM; Takou D; Tala V; Beloumou G; Ngoufack ES; Chenwi C; Pabo Willy Leroi T; Njume D; Teto G; Dambaya B; Djupsa S; Sosso S; Ateba F; Kamta C; Bala L; Njom Nlend AE; Koki Ndombo P; Colizzi V; Perno CF; Ndjolo A
HIV Med; 2022 Jul; 23(6):629-638. PubMed ID: 34951111
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment HIV Drug Resistance and Virologic Outcomes to First-Line Antiretroviral Therapy in Peru.
Soria J; Mugruza R; Levine M; León SR; Arévalo J; Ticona E; Beck IA; Frenkel LM
AIDS Res Hum Retroviruses; 2019 Feb; 35(2):150-154. PubMed ID: 30560685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
